Simple Summary The immune system provides surveillance measures to identify and
remove damaged cell types at an early stage. One important example involves the NKG2D …

Immunotherapy using chimeric antigen receptor (CAR)-engineered T-cells has achieved
unprecedented efficacy in selected hematological cancers. However, solid tumors such as …

Leveraging the specificity of antibody to deliver cytotoxic agent into tumor, antibody-drug
conjugates (ADCs) have become one of the hotspots in the development of anticancer …

Prostate cancer is primarily hormone-dependent, and medical treatments have focused on
inhibiting androgen biosynthesis or signaling through various approaches. Despite …

Lung adenocarcinoma (LUAD) is a tumour characterized by high tumour heterogeneity.
Although there are numerous prognostic and immunotherapeutic options available for …

The incidence of androgen receptor (AR)–negative (AR−) prostate cancer, including
aggressive neuroendocrine prostate cancer (NEPC), has more than doubled in the last …

Résumé Le développement croissant des anticorps conjugués à des molécules
cytotoxiques (ADCs pour Antibody drug conjugates) comme nouvelle stratégie …

Identification of accurate biomarkers is still particularly urgent for improving the poor survival
of chronic obstructive pulmonary disease (COPD) patients. In this investigation, we aimed to …

The Role of Chemistry in Contribution to Biomedicine Recently Page 1 Journal of Clinical and
Biomedical Advances www.mkscienceset.com J Clin Bio Med Adv 2024 Research Article The …

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment
option for various types of cancers. Although it has shown remarkable effectiveness, this …